Melanoma - Biologically Targeted Therapeutics - Current Clinical Oncology

Idioma: inglés

Editorial: Humana Press Inc, Totowa, New Jersey, USA, 2002

0896038769 / 9780896038769

  • Primera edición
  • Tapa dura
  • Nuevo
Ver todos los detalles

Librería: CURIO, Cleethorpes, North East Lincolnshire, Reino UnidoCURIO

Vendedor de 5 estrellas

Vendedor de IberLibro desde 6 de septiembre de 2017

Tapa dura

Condición: Nuevo

EUR 43,22

Envío por EUR 35,96 
Se envía de Reino Unido a Estados Unidos de America

Cantidad disponible: 2 disponibles

Añadir al carrito
Devoluciones gratuitas de 30 días

Descripción del artículo del vendedor

Brand New. First Edition / First Print (number line on copyright page 10 9 8 7 6 5 4 3 2 1). Hardback copy in pictorial boards, no dustjacket as issued. 389pp. Colour plates. Strategies of treatment involving therapeutic proteins, irnrnune immune cells, or cel­ lular protein targets are those of greatest potential for further reducing mortality from melanoma. Therapeutic proteins or cells may inhibit melanoma cell growth either by augmentation of immune cell function or by inhibition of angiogenesis. Cytokines and melanoma antigens may be used either in vivo as a vaccine to stimulate irnrnune immune cell cell function or ex vivo to stimulate or proliferate cells for infusion. Alternatively, alteration in melanoma cell growth can occur through inhibition of protein signal transduction pathways within melanoma cells or in the endothelial cells constituting the necessary angiogenic support for tumor growth. The great promise of these therapies and their cellular targets constitutes the basis for Melanoma: Biologically Targeted Therapeutics. THE CLINlCAL PROBLEM More than four million people will be diagnosed with melanoma in the first decade of the 21st century. Half of those who will die will be individuals who would otherwise have had a life expectancy of another 25 years or more. These individuals will die of systemic systernic metastases, which are present at the time of primary surgery. Despite use of sunscreens, incidence continues to increase in developed countries worldwide. To reduce mortality, there must continue to be a focus on prevention and earlier detection through public education. Early interventions are always preferable to treatment of disseminated metastatic disease. (35/1).…

Título
Melanoma - Biologically Targeted Therapeutics - Current Clinical Oncology
Autor
Borden, Ernest C (edited)
Editorial
Humana Press Inc, Totowa, New Jersey, USA
Año de publicación
2002
Estado
New
Sobrecubierta
No Jacket
Encuadernación
Hardcover
Idioma
inglés
ISBN 10
0896038769
ISBN 13
9780896038769
Edición
1st Edition

CURIO

Cleethorpes, North East Lincolnshire, Reino Unido

Vendedor de 5 estrellas

Vendedor de IberLibro desde 6 de septiembre de 2017

Tarifas de envío de Reino Unido a Estados Unidos de America

ArtículoDe 8 a 21 días hábilesDe 5 a 7 días hábiles
Primer artículoEUR 35,96EUR 47,95
Los plazos de entrega los establecen los vendedores y varían según el transportista y la ubicación. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relación con cargos adicionales para cubrir cualquier aumento en los costes de envío de los artículos.

Métodos de pago

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Descripción de la tienda

CURIO was established in 1999 in Bingham, a town 10 miles from the city of Nottingham, Nottinghamshire, before relocating to Grimsby, North East Lincolnshire in 2007. As of 2025 we are now in Cleethorpes, North East Lincolnshire. We have a wide selection of stock comprising of first editions, fiction and non-fiction, signed and limited editions, children's books, and antiquarian books.

Especialidad

First editions, fiction and non-fiction, signed and limited editions, children's books, and antiquarian books.